Lack of association between 11C-PiB and longitudinal brain atrophy in non-demented older individuals
暂无分享,去创建一个
Christos Davatzikos | Susan M. Resnick | Luigi Ferrucci | Michael A. Kraut | Dean F. Wong | Yun Zhou | Weiguo Ye | Ira Driscoll | William E. Klunk | Chester A. Mathis | L. Ferrucci | S. Resnick | C. Davatzikos | M. Kraut | Y. An | W. Klunk | C. Mathis | D. Wong | I. Driscoll | J. Sojkova | W. Ye | Yun Zhou | Jitka Sojkova | Yang An
[1] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[2] S. Resnick,et al. Longitudinal Magnetic Resonance Imaging Studies of Older Adults: A Shrinking Brain , 2003, The Journal of Neuroscience.
[3] J. Morris,et al. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage alzheimer’s disease , 2001, Journal of Molecular Neuroscience.
[4] S. DeKosky,et al. Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] Mark A Mintun,et al. Utilizing Advanced Imaging and Surrogate Markers Across the Spectrum of Alzheimer's Disease , 2005, CNS Spectrums.
[6] Ira Driscoll,et al. Impact of Alzheimer's pathology on cognitive trajectories in nondemented elderly , 2006, Annals of neurology.
[7] Sung-Cheng Huang,et al. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model , 2003, NeuroImage.
[8] S. Resnick,et al. Longitudinal pattern of regional brain volume change differentiates normal aging from MCI , 2009, Neurology.
[9] Christos Davatzikos,et al. Voxel-Based Morphometry Using the RAVENS Maps: Methods and Validation Using Simulated Longitudinal Atrophy , 2001, NeuroImage.
[10] Gina N. LaRossa,et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.
[11] M. Albert,et al. Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain , 2004, Neurology.
[12] H. Braak,et al. Postmortale Diagnosestellung bei Morbus Alzheimer , 2005, Der Pathologe.
[13] C. Rowe,et al. Aβ deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease , 2008, Neuropsychologia.
[14] S. Resnick,et al. One-year age changes in MRI brain volumes in older adults. , 2000, Cerebral cortex.
[15] A. Nordberg. Amyloid plaque imaging in vivo: current achievement and future prospects , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[16] H Braak,et al. [Post-mortem diagnosis of Alzheimer's disease]. , 2005, Der Pathologe.
[17] J E Smialek,et al. Neuropathology of preclinical and clinical lateonset Alzheimer's disease , 1998, Annals of neurology.
[18] C. Rowe,et al. Imaging β-amyloid burden in aging and dementia , 2007, Neurology.
[19] A. Fagan,et al. Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderly , 2009, Annals of neurology.
[20] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[21] C. Jack,et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.
[22] J. Schneider,et al. Neuropathology of older persons without cognitive impairment from two community-based studies , 2006, Neurology.
[23] C. Jack,et al. Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease , 2004, NeuroRX.
[24] Nick C Fox,et al. The natural history of Alzheimer disease: a longitudinal presymptomatic and symptomatic study of a familial cohort. , 2004, Archives of neurology.
[25] Sanjiv Sam Gambhir,et al. AMIDE: a free software tool for multimodality medical image analysis. , 2003, Molecular imaging.
[26] J. Hardy,et al. The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .
[27] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[28] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[29] J. Morris,et al. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease , 1999, Annals of neurology.
[30] C. Rowe,et al. Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B. , 2007, Archives of neurology.
[31] Yun Zhou,et al. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease , 2007, NeuroImage.
[32] H. Braak,et al. Evolution of neuronal changes in the course of Alzheimer's disease. , 1998, Journal of neural transmission. Supplementum.
[33] A. Alzheimer. Uber eine eigenartige Erkrankung der Hirnrinde , 1907 .
[34] M. Roth,et al. The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects , 1968, British Journal of Psychiatry.
[35] J. Morris,et al. Mild cognitive impairment as a clinical entity and treatment target. , 2005, Archives of neurology.
[36] Dinggang Shen,et al. HAMMER: hierarchical attribute matching mechanism for elastic registration , 2002, IEEE Transactions on Medical Imaging.
[37] S. Resnick,et al. An image-processing system for qualitative and quantitative volumetric analysis of brain images. , 1998, Journal of computer assisted tomography.
[38] R Brookmeyer,et al. Visual memory predicts Alzheimer’s disease more than a decade before diagnosis , 2003, Neurology.
[39] R Brookmeyer,et al. Age-specific incidence rates of Alzheimer’s disease , 2000, Neurology.
[40] R. Torack. Adult dementia: history, biopsy, pathology. , 1979, Neurosurgery.